This study adds to the accumulating evidence that negative regulation of AT1R signaling by ATRAP is a predictor of sustained favorable PVAT effects and highlights the importance of PVAT RAS overactivation in vascular dysfunction and MetS. Here, AGTRAP is linked to metabolic syndrome.